Stuart A. Arbuckle - 17 Feb 2022 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
EVP, COO
Signature
/s/ Sabrina Yohai, Attorney-in-Fact
Issuer symbol
VRTX
Transactions as of
17 Feb 2022
Net transactions value
-$959,336
Form type
4
Filing time
22 Feb 2022, 15:54:01 UTC
Previous filing
14 Feb 2022
Next filing
28 Feb 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Tax liability $959,336 -4,126 -5.4% $232.51 72,312 17 Feb 2022 Direct
holding VRTX Common Stock 140 17 Feb 2022 401(k)
* An asterisk sign (*) next to the price indicates that the price is likely invalid.